Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Human Natural Killer Receptors, Co-Receptors, and Their Ligands.

Biassoni R, Malnati MS.

Curr Protoc Immunol. 2018 Apr;121(1):e47. doi: 10.1002/cpim.47.

PMID:
30040219
2.

Interdomain Stabilization Impairs CD4 Binding and Improves Immunogenicity of the HIV-1 Envelope Trimer.

Zhang P, Gorman J, Geng H, Liu Q, Lin Y, Tsybovsky Y, Go EP, Dey B, Andine T, Kwon A, Patel M, Gururani D, Uddin F, Guzzo C, Cimbro R, Miao H, McKee K, Chuang GY, Martin L, Sironi F, Malnati MS, Desaire H, Berger EA, Mascola JR, Dolan MA, Kwong PD, Lusso P.

Cell Host Microbe. 2018 Jun 13;23(6):832-844.e6. doi: 10.1016/j.chom.2018.05.002.

3.

Activating Killer Immunoglobulin Receptors and HLA-C: a successful combination providing HIV-1 control.

Malnati MS, Ugolotti E, Monti MC, Battista D, Vanni I, Bordo D, Sironi F, Larghero P, Marco ED, Biswas P, Poli G, Vicenzi E, Riva A, Tarkowski M, Tambussi G, Nozza S, Tripodi G, Marras F, De Maria A, Pistorio A, Biassoni R.

Sci Rep. 2017 Feb 13;7:42470. doi: 10.1038/srep42470.

4.

HHV-8 DNA replication correlates with the clinical status in AIDS-related Kaposi's sarcoma.

Broccolo F, Tassan Din C, Viganò MG, Rutigliano T, Esposito S, Lusso P, Tambussi G, Malnati MS.

J Clin Virol. 2016 May;78:47-52. doi: 10.1016/j.jcv.2016.02.019. Epub 2016 Feb 26.

PMID:
26985593
5.

Spontaneous control of HIV-1 viremia in a subject with protective HLA-B plus HLA-C alleles and HLA-C associated single nucleotide polymorphisms.

Moroni M, Ghezzi S, Baroli P, Heltai S, De Battista D, Pensieroso S, Cavarelli M, Dispinseri S, Vanni I, Pastori C, Zerbi P, Tosoni A, Vicenzi E, Nebuloni M, Wong K, Zhao H, McHugh S, Poli G, Lopalco L, Scarlatti G, Biassoni R, Mullins JI, Malnati MS, Alfano M.

J Transl Med. 2014 Dec 5;12:335. doi: 10.1186/s12967-014-0335-6.

6.

Absolute quantification of viral DNA: the quest for perfection.

Russo D, Malnati MS.

Methods Mol Biol. 2014;1160:75-86. doi: 10.1007/978-1-4939-0733-5_7.

PMID:
24740222
7.

Selective reactivation of human herpesvirus 6 in patients with autoimmune connective tissue diseases.

Broccolo F, Drago F, Cassina G, Fava A, Fusetti L, Matteoli B, Ceccherini-Nelli L, Sabbadini MG, Lusso P, Parodi A, Malnati MS.

J Med Virol. 2013 Nov;85(11):1925-34. doi: 10.1002/jmv.23670.

PMID:
23983182
8.

Calibrated real-time polymerase chain reaction for specific quantitation of HHV-6A and HHV-6B in clinical samples.

Cassina G, Russo D, De Battista D, Broccolo F, Lusso P, Malnati MS.

J Virol Methods. 2013 Apr;189(1):172-9. doi: 10.1016/j.jviromet.2013.01.018. Epub 2013 Feb 4.

PMID:
23391825
9.

Comparison of oncogenic HPV type-specific viral DNA load and E6/E7 mRNA detection in cervical samples: results from a multicenter study.

Broccolo F, Fusetti L, Rosini S, Caraceni D, Zappacosta R, Ciccocioppo L, Matteoli B, Halfon P, Malnati MS, Ceccherini-Nelli L.

J Med Virol. 2013 Mar;85(3):472-82. doi: 10.1002/jmv.23487. Epub 2012 Dec 26.

PMID:
23280876
10.

Treatment with IL-7 prevents the decline of circulating CD4+ T cells during the acute phase of SIV infection in rhesus macaques.

Vassena L, Miao H, Cimbro R, Malnati MS, Cassina G, Proschan MA, Hirsch VM, Lafont BA, Morre M, Fauci AS, Lusso P.

PLoS Pathog. 2012;8(4):e1002636. doi: 10.1371/journal.ppat.1002636. Epub 2012 Apr 12.

11.

A new antigen scanning strategy for monitoring HIV-1 specific T-cell immune responses.

Malnati MS, Heltai S, Cosma A, Reitmeir P, Allgayer S, Glashoff RH, Liebrich W, Vardas E, Imami N, Westrop S, Nozza S, Tambussi G, Buttò S, Fanales-Belasio E, Ensoli B, Ensoli F, Tripiciano A, Fortis C, Lusso P, Poli G, Erfle V, Holmes H.

J Immunol Methods. 2012 Jan 31;375(1-2):46-56. doi: 10.1016/j.jim.2011.09.005. Epub 2011 Sep 22.

PMID:
21963950
12.

A multiplex calibrated real-time PCR assay for quantitation of DNA of EBV-1 and 2.

Gatto F, Cassina G, Broccolo F, Morreale G, Lanino E, Di Marco E, Vardas E, Bernasconi D, Buttò S, Principi N, Esposito S, Scarlatti G, Lusso P, Malnati MS.

J Virol Methods. 2011 Dec;178(1-2):98-105. doi: 10.1016/j.jviromet.2011.08.022. Epub 2011 Aug 27.

PMID:
21903135
13.

Reactivation of human herpesvirus 6 (HHV-6) infection in patients with connective tissue diseases.

Broccolo F, Drago F, Paolino S, Cassina G, Gatto F, Fusetti L, Matteoli B, Zaccaria E, Parodi A, Lusso P, Ceccherini-Nelli L, Malnati MS.

J Clin Virol. 2009 Sep;46(1):43-6. doi: 10.1016/j.jcv.2009.05.010. Epub 2009 Jun 9.

PMID:
19515610
14.

A universal real-time PCR assay for the quantification of group-M HIV-1 proviral load.

Malnati MS, Scarlatti G, Gatto F, Salvatori F, Cassina G, Rutigliano T, Volpi R, Lusso P.

Nat Protoc. 2008;3(7):1240-8. doi: 10.1038/nprot.2008.108.

PMID:
18600229
15.

Multicenter comparison of PCR assays for detection of human herpesvirus 6 DNA in serum.

Flamand L, Gravel A, Boutolleau D, Alvarez-Lafuente R, Jacobson S, Malnati MS, Kohn D, Tang YW, Yoshikawa T, Ablashi D.

J Clin Microbiol. 2008 Aug;46(8):2700-6. doi: 10.1128/JCM.00370-08. Epub 2008 Jun 11. Erratum in: J Clin Microbiol. 2009 Feb;47(2):519.

16.

Human herpesvirus 6A accelerates AIDS progression in macaques.

Lusso P, Crowley RW, Malnati MS, Di Serio C, Ponzoni M, Biancotto A, Markham PD, Gallo RC.

Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):5067-72. Epub 2007 Mar 14.

17.

Differentiated human neural stem cells: a new ex vivo model to study HHV-6 infection of the central nervous system.

De Filippis L, Foglieni C, Silva S, Vescovi AL, Lusso P, Malnati MS.

J Clin Virol. 2006 Dec;37 Suppl 1:S27-32.

PMID:
17276364
18.

Viral interactions in human lymphoid tissue: Human herpesvirus 7 suppresses the replication of CCR5-tropic human immunodeficiency virus type 1 via CD4 modulation.

Lisco A, Grivel JC, Biancotto A, Vanpouille C, Origgi F, Malnati MS, Schols D, Lusso P, Margolis LB.

J Virol. 2007 Jan;81(2):708-17. Epub 2006 Oct 25.

19.

Preparing for phase II/III HIV vaccine trials in Africa.

Vardas E, Buttò S, Glashoff R, Malnati MS, Poli G, Clerici M.

Microbes Infect. 2005 Nov;7(14):1436-44. Epub 2005 Sep 26.

PMID:
16257561
20.

Productive infection of HUVEC by HHV-8 is associated with changes compatible with angiogenic transformations.

Foglieni C, Scabini S, Belloni D, Broccolo F, Lusso P, Malnati MS, Ferrero E.

Eur J Histochem. 2005 Jul-Sep;49(3):273-84.

PMID:
16216813
21.

A relapsing inflammatory syndrome and active human herpesvirus 8 infection.

Dagna L, Broccolo F, Paties CT, Ferrarini M, Sarmati L, Praderio L, Sabbadini MG, Lusso P, Malnati MS.

N Engl J Med. 2005 Jul 14;353(2):156-63.

22.

Additional evidence that pityriasis rosea is associated with reactivation of human herpesvirus-6 and -7.

Broccolo F, Drago F, Careddu AM, Foglieni C, Turbino L, Cocuzza CE, Gelmetti C, Lusso P, Rebora AE, Malnati MS.

J Invest Dermatol. 2005 Jun;124(6):1234-40.

23.

Human herpesvirus 8 (HHV-8/KSHV) and hematologic malignancies.

Malnati MS, Dagna L, Ponzoni M, Lusso P.

Rev Clin Exp Hematol. 2003 Dec;7(4):375-405. Review.

PMID:
15129649
24.

Rapid diagnosis of mycobacterial infections and quantitation of Mycobacterium tuberculosis load by two real-time calibrated PCR assays.

Broccolo F, Scarpellini P, Locatelli G, Zingale A, Brambilla AM, Cichero P, Sechi LA, Lazzarin A, Lusso P, Malnati MS.

J Clin Microbiol. 2003 Oct;41(10):4565-72.

25.

Pathogenic effects of human herpesvirus 6 in human lymphoid tissue ex vivo.

Grivel JC, Santoro F, Chen S, Fagá G, Malnati MS, Ito Y, Margolis L, Lusso P.

J Virol. 2003 Aug;77(15):8280-9.

26.

Calibrated real-time PCR assay for quantitation of human herpesvirus 8 DNA in biological fluids.

Broccolo F, Locatelli G, Sarmati L, Piergiovanni S, Veglia F, Andreoni M, Buttò S, Ensoli B, Lusso P, Malnati MS.

J Clin Microbiol. 2002 Dec;40(12):4652-8.

27.

Suppression of CCR5- but not CXCR4-tropic HIV-1 in lymphoid tissue by human herpesvirus 6.

Grivel JC, Ito Y, Fagà G, Santoro F, Shaheen F, Malnati MS, Fitzgerald W, Lusso P, Margolis L.

Nat Med. 2001 Nov;7(11):1232-5.

PMID:
11689888
28.

Real-time quantitative PCR for human herpesvirus 6 DNA.

Locatelli G, Santoro F, Veglia F, Gobbi A, Lusso P, Malnati MS.

J Clin Microbiol. 2000 Nov;38(11):4042-8.

29.

Coinfection of SCID-hu Thy/Liv mice with human herpesvirus 6 and human immunodeficiency virus type 1.

Gobbi A, Stoddart CA, Locatelli G, Santoro F, Bare C, Linquist-Stepps V, Moreno ME, Abbey NW, Herndier BG, Malnati MS, McCune JM, Lusso P.

J Virol. 2000 Sep;74(18):8726-31.

30.

Analysis of serum and plasma beta chemokines in primary HIV infection (PHI).

Malnati MS, Tambussi G, Fischetti L, Algeri M, Veglia F, Capiluppi B, Lazzarin A, Lusso P.

J Biol Regul Homeost Agents. 2000 Jan-Mar;14(1):75-8.

PMID:
10763899
31.

CD46 is a cellular receptor for human herpesvirus 6.

Santoro F, Kennedy PE, Locatelli G, Malnati MS, Berger EA, Lusso P.

Cell. 1999 Dec 23;99(7):817-27.

32.

Human herpesvirus 6 (HHV-6) causes severe thymocyte depletion in SCID-hu Thy/Liv mice.

Gobbi A, Stoddart CA, Malnati MS, Locatelli G, Santoro F, Abbey NW, Bare C, Linquist-Stepps V, Moreno MB, Herndier BG, Lusso P, McCune JM.

J Exp Med. 1999 Jun 21;189(12):1953-60.

33.

Longitudinal analysis of serum chemokine levels in the course of HIV-1 infection.

Polo S, Veglia F, Malnati MS, Gobbi C, Farci P, Raiteri R, Sinicco A, Lusso P.

AIDS. 1999 Mar 11;13(4):447-54.

PMID:
10197372
34.

In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression.

Scarlatti G, Tresoldi E, Björndal A, Fredriksson R, Colognesi C, Deng HK, Malnati MS, Plebani A, Siccardi AG, Littman DR, Fenyö EM, Lusso P.

Nat Med. 1997 Nov;3(11):1259-65.

PMID:
9359702
35.

Increased plasma levels of the C-C chemokine RANTES in patients with primary HIV-1 infection.

Malnati MS, Tambussi G, Clerici E, Polo S, Algeri M, Nardese V, Furci L, Lazzarin A, Lusso P.

J Biol Regul Homeost Agents. 1997 Jan-Jun;11(1-2):40-2.

PMID:
9418160
36.

Peptide sequence requirements for the recognition of HLA-B*2705 by specific natural killer cells.

Peruzzi M, Parker KC, Long EO, Malnati MS.

J Immunol. 1996 Oct 15;157(8):3350-6.

PMID:
8871631
37.

Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains.

Wagtmann N, Biassoni R, Cantoni C, Verdiani S, Malnati MS, Vitale M, Bottino C, Moretta L, Moretta A, Long EO.

Immunity. 1995 May;2(5):439-49.

38.
39.

Peptide specificity in the recognition of MHC class I by natural killer cell clones.

Malnati MS, Peruzzi M, Parker KC, Biddison WE, Ciccone E, Moretta A, Long EO.

Science. 1995 Feb 17;267(5200):1016-8.

PMID:
7863326
40.

Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen.

Pinet V, Malnati MS, Long EO.

J Immunol. 1994 May 15;152(10):4852-60.

PMID:
8176208
41.

Presentation of cytosolic antigen by HLA-DR requires a function encoded in the class II region of the MHC.

Malnati MS, Ceman S, Weston M, DeMars R, Long EO.

J Immunol. 1993 Dec 15;151(12):6751-6.

PMID:
8258689
42.

Recognition of virus-infected cells by natural killer cell clones is controlled by polymorphic target cell elements.

Malnati MS, Lusso P, Ciccone E, Moretta A, Moretta L, Long EO.

J Exp Med. 1993 Sep 1;178(3):961-9.

43.

Infection of natural killer cells by human herpesvirus 6.

Lusso P, Malnati MS, Garzino-Demo A, Crowley RW, Long EO, Gallo RC.

Nature. 1993 Apr 1;362(6419):458-62.

PMID:
7681936
44.

Processing pathways for presentation of cytosolic antigen to MHC class II-restricted T cells.

Malnati MS, Marti M, LaVaute T, Jaraquemada D, Biddison W, DeMars R, Long EO.

Nature. 1992 Jun 25;357(6380):702-4.

PMID:
1614517
45.

Clonal analysis of joint fluid T lymphocytes in patients with juvenile rheumatoid arthritis.

De Maria AF, Malnati MS, Poggi A, Pende D, Cottafava F, Moretta L.

J Rheumatol. 1990 Aug;17(8):1073-8.

PMID:
2213782

Supplemental Content

Loading ...
Support Center